Cytosorbents Crp Stock Probability of Future Stock Price Finishing Over 0.93

CTSO Stock  USD 0.93  0.04  4.49%   
Cytosorbents Crp's implied volatility is one of the determining factors in the pricing options written on Cytosorbents Crp. Implied volatility approximates the future value of Cytosorbents Crp based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Cytosorbents Crp over a specific time period. For example, 2024-04-19 PUT at $2.5 is a PUT option contract on Cytosorbents Crp's common stock with a strick price of 2.5 expiring on 2024-04-19. The contract was not traded in recent days and, as of today, has 22 days remaining before the expiration. The option is currently trading at a bid price of $1.2, and an ask price of $2.25. The implied volatility as of the 28th of March is 385.49. View All Cytosorbents options

Closest to current price Cytosorbents long PUT Option Payoff at Expiration

Cytosorbents Crp's future price is the expected price of Cytosorbents Crp instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Cytosorbents Crp performance during a given time horizon utilizing its historical volatility. Check out Cytosorbents Crp Backtesting, Cytosorbents Crp Valuation, Cytosorbents Crp Correlation, Cytosorbents Crp Hype Analysis, Cytosorbents Crp Volatility, Cytosorbents Crp History as well as Cytosorbents Crp Performance.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.
  
At this time, Cytosorbents Crp's Price Book Value Ratio is very stable compared to the past year. As of the 28th of March 2024, Price Earnings To Growth Ratio is likely to grow to 0.12, while Price Earnings Ratio is likely to drop (1.83). Please specify Cytosorbents Crp's target price for which you would like Cytosorbents Crp odds to be computed.

Cytosorbents Crp Target Price Odds to finish over 0.93

The tendency of Cytosorbents Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.93 90 days 0.93 
about 68.21
Based on a normal probability distribution, the odds of Cytosorbents Crp to move above the current price in 90 days from now is about 68.21 (This Cytosorbents Crp probability density function shows the probability of Cytosorbents Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Cytosorbents Crp has a beta of 0.5 suggesting as returns on the market go up, Cytosorbents Crp average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cytosorbents Crp will be expected to be much smaller as well. Additionally Cytosorbents Crp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
   Cytosorbents Crp Price Density   
       Price  

Predictive Modules for Cytosorbents Crp

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cytosorbents Crp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytosorbents Crp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.050.944.44
Details
Intrinsic
Valuation
LowRealHigh
0.132.586.08
Details
Naive
Forecast
LowNextHigh
0.020.884.38
Details
2 Analysts
Consensus
LowTargetHigh
6.987.678.51
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cytosorbents Crp. Your research has to be compared to or analyzed against Cytosorbents Crp's peers to derive any actionable benefits. When done correctly, Cytosorbents Crp's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cytosorbents Crp.

Cytosorbents Crp Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cytosorbents Crp is not an exception. The market had few large corrections towards the Cytosorbents Crp's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cytosorbents Crp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cytosorbents Crp within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.94
β
Beta against NYSE Composite0.50
σ
Overall volatility
0.19
Ir
Information ratio -0.19

Cytosorbents Crp Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cytosorbents Crp for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cytosorbents Crp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cytosorbents Crp generated a negative expected return over the last 90 days
Cytosorbents Crp has some characteristics of a very speculative penny stock
Cytosorbents Crp has high historical volatility and very poor performance
Cytosorbents Crp has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 36.35 M. Net Loss for the year was (28.51 M) with profit before overhead, payroll, taxes, and interest of 20.73 M.
Cytosorbents Crp currently holds about 30.16 M in cash with (21.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.69.
Cytosorbents Crp has a frail financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Acquisition by Alan Sobel of 22557 shares of Cytosorbents Crp at 1.33 subject to Rule 16b-3

Cytosorbents Crp Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cytosorbents Stock often depends not only on the future outlook of the current and potential Cytosorbents Crp's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytosorbents Crp's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding44.7 M
Cash And Short Term Investments14.1 M

Cytosorbents Crp Technical Analysis

Cytosorbents Crp's future price can be derived by breaking down and analyzing its technical indicators over time. Cytosorbents Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cytosorbents Crp. In general, you should focus on analyzing Cytosorbents Stock price patterns and their correlations with different microeconomic environments and drivers.

Cytosorbents Crp Predictive Forecast Models

Cytosorbents Crp's time-series forecasting models is one of many Cytosorbents Crp's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cytosorbents Crp's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Cytosorbents Crp

Checking the ongoing alerts about Cytosorbents Crp for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cytosorbents Crp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cytosorbents Crp generated a negative expected return over the last 90 days
Cytosorbents Crp has some characteristics of a very speculative penny stock
Cytosorbents Crp has high historical volatility and very poor performance
Cytosorbents Crp has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 36.35 M. Net Loss for the year was (28.51 M) with profit before overhead, payroll, taxes, and interest of 20.73 M.
Cytosorbents Crp currently holds about 30.16 M in cash with (21.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.69.
Cytosorbents Crp has a frail financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Acquisition by Alan Sobel of 22557 shares of Cytosorbents Crp at 1.33 subject to Rule 16b-3
When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock:

Complementary Tools for Cytosorbents Stock analysis

When running Cytosorbents Crp's price analysis, check to measure Cytosorbents Crp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytosorbents Crp is operating at the current time. Most of Cytosorbents Crp's value examination focuses on studying past and present price action to predict the probability of Cytosorbents Crp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytosorbents Crp's price. Additionally, you may evaluate how the addition of Cytosorbents Crp to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is Cytosorbents Crp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.64)
Revenue Per Share
0.814
Quarterly Revenue Growth
(0.08)
Return On Assets
(0.32)
Return On Equity
(0.97)
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.